Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III echo-guided ibuprofen regimens for patent ductus arteriosus in preterm infants
2016-002974-11Phase 3Active
- Sponsor
- MarÃa Carmen Bravo Laguna
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ibuprofen in patent ductus arteriosus (PDA) (2 arms), sponsored by MarÃa Carmen Bravo Laguna. Primary endpoint: Incidence of necrotizing enterocolitis or acute intestinal perforation. Started Sep 2016; status: active.
02
Drugs
ibuprofen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on 2016-002974-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002974-11.